Journal of Cancer Therapy
Vol.3 No.6A(2012), Paper ID 25171, 7
pages
DOI:10.4236/jct.2012.326120
sTRAIL Serum Levels and TRAIL 1595 Genotypes: Associations with Progress and Prognosis of Colorectal Carcinoma
İlhan Yaylım, Nazlı Ezgi Ozkan, Saime Turan, Gurbet Korkmaz, Yemliha Yıldız, Canan Cacina, Bahar Toptaş, Soykan Arıkan
Department of Molecular Medicine, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey
Department of Molecular Medicine, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey;
Department of Molecular Medicine, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey;
Department of Molecular Medicine, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey;
Department of Molecular Medicine, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey;
Department of Molecular Medicine, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey;
Department of Molecular Medicine, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey;
Surgery Clinic, Istanbul Education and Research Hospital, Istanbul, Turkey.
Copyright © 2012 İlhan Yaylım, Nazlı Ezgi Ozkan, Saime Turan, Gurbet Korkmaz, Yemliha Yıldız, Canan Cacina, Bahar Toptaş, Soykan Arıkan et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
İ. Yaylım, N. Ozkan, S. Turan, G. Korkmaz, Y. Yıldız, C. Cacina, B. Toptaş and S. Arıkan, "sTRAIL Serum Levels and TRAIL 1595 Genotypes: Associations with Progress and Prognosis of Colorectal Carcinoma,"
Journal of Cancer Therapy, Vol. 3 No. 6A, 2012, pp. 941-947. doi:
10.4236/jct.2012.326120.